Diploidy alters the path of fluconazole adaptation in Candida glabrata
- 1University of Pennsylvania
Abstract
Candida glabrata (syn. Nakaseomyces glabratus) is a major fungal pathogen, typically isolated as a haploid. We isolated a spontaneous diploid variant of the type strain CBS138 and performed experimental evolution under fluconazole. At physiologically relevant concentrations of fluconazole, we found that haploids and diploids both acquired PDR1 mutations, as is commonly observed in C. glabrata; diploids additionally acquired heterozygous ERG11 and ERG25 mutations and were more likely to acquire aneuploidies. Despite an ancestral fitness advantage for haploids, after ~200 generations the highest-fitness clones, as measured in competitive assays with and without fluconazole, were diploid double heterozygotes having nonsynonymous mutations to PDR1 and ERG11 or PDR1 and ERG25. Diploid clones also had higher MICs. These results suggest, in this particular context, an evolvability advantage for diploids. In a follow-up experiment in which we rapidly increased the fluconazole concentration to a very high concentration, haploids and diploids adapted via entirely distinct routes: haploids via co-mutation in ERG3 and CgOSH3, a previously unreported path to fluconazole resistance, and diploids via heterozygous mutation in ERG25 coupled with trisomies of chrF, chrG, and chrI in all sampled clones, and chrC in most sampled clones.
Related
- Thirty years of fluconazole therapy selects an azole-resistant Candida albicans isolate with a pre-adapted physiological, metabolic and structural state
- Diverse genetic pathways drive convergent fluconazole and caspofungin resistance phenotypes in Candida albicans
- Repurposing amlodipine, fluoxetine, and escitalopram as non-antibiotic adjuvants: in vitro enhancement of ciprofloxacin and fluconazole activity against multidrug-resistant bacterial and candida clinical isolates.
- Outbreaks of fluconazole-resistant Candida parapsilosis are driven by low-biofilm-producing isolates that emerge under host selection
- The influence of drug dosing regimen on extinction and adaptation during experimental evolution in Candida albicans
BibTeX
@misc{galeotasprung2026diploidy,
title = {{Diploidy alters the path of fluconazole adaptation in Candida glabrata}},
author = {B. Galeota-Sprung and A. Fernandez and C. Wright and R. Soto Tejada and P. Sniegowski},
howpublished = {bioRxiv},
year = {2026},
month = may,
doi = {10.64898/2026.05.22.727327},
url = {https://www.biorxiv.org/content/10.64898/2026.05.22.727327v4},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Diploidy alters the path of fluconazole adaptation in Candida glabrata
AU - B. Galeota-Sprung
AU - A. Fernandez
AU - C. Wright
AU - R. Soto Tejada
AU - P. Sniegowski
PY - 2026
DA - 2026/05/22
PB - bioRxiv
DO - 10.64898/2026.05.22.727327
UR - https://www.biorxiv.org/content/10.64898/2026.05.22.727327v4
AB - Candida glabrata (syn. Nakaseomyces glabratus) is a major fungal pathogen, typically isolated as a haploid. We isolated a spontaneous diploid variant of the type strain CBS138 and performed experimental evolution under fluconazole. At physiologically relevant concentrations of fluconazole, we found that haploids and diploids both acquired PDR1 mutations, as is commonly observed in C. glabrata; diploids additionally acquired heterozygous ERG11 and ERG25 mutations and were more likely to acquire aneuploidies. Despite an ancestral fitness advantage for haploids, after ~200 generations the highest-fitness clones, as measured in competitive assays with and without fluconazole, were diploid double heterozygotes having nonsynonymous mutations to PDR1 and ERG11 or PDR1 and ERG25. Diploid clones also had higher MICs. These results suggest, in this particular context, an evolvability advantage for diploids. In a follow-up experiment in which we rapidly increased the fluconazole concentration to a very high concentration, haploids and diploids adapted via entirely distinct routes: haploids via co-mutation in ERG3 and CgOSH3, a previously unreported path to fluconazole resistance, and diploids via heterozygous mutation in ERG25 coupled with trisomies of chrF, chrG, and chrI in all sampled clones, and chrC in most sampled clones.
ER -